Centre for Addiction and Mental Health: all 339 studies

Page 3 of 4. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.

• The Efficacy of the Alcooquizz App to Reduce Hazardous Alcohol ConsumptionCompletedNCT03008928Not applicable
• Efficacy of Cognitive Bias Modification in Residential Treatment for AddictionCompletedNCT03000699Not applicable
• Personalized Dosing of Nicotine Replacement (NRT to Effect)CompletedNCT03000387Phase 4
• Conventional Bilateral rTMS vs. Bilateral Theta Burst Stimulation for Late-Life DepressionCompletedNCT02998580Not applicable
• Investigating Psychosocial Intervention Treatment Response in Justice-Involved Youth With Conduct DisorderCompletedNCT02998073Not applicable
• Comparing the Efficacy of the Alcohol Help Centre and Check Your Drinking to a no Intervention Control ConditionCompletedNCT02977026Not applicable
• Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life DepressionActive, not recruitingNCT02959502Not applicable
• CAMH - McMaster Collaborative Care Initiative For Mental Health Risk Factors In DementiaCompletedNCT02955719Not applicable
• tDCS Coupled With Virtual Rehabilitation for Negative Symptoms in At-Risk YouthStatus unknownNCT02951208Not applicable
• RCT Examining the Effectiveness of Digital Picture Frame Use in Inpatient SettingCompletedNCT02950571Not applicable
• Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic PolymorphismsCompletedNCT02921282
• Brief Internet Intervention for Hazardous Alcohol UseCompletedNCT02905123Not applicable
• Clinical and Biological Markers of Response to Cognitive Behavioural Therapy for DepressionCompletedNCT02883257Not applicable
• The Effects of tDCS on Illness Awareness in SchizophreniaCompletedNCT02848885Not applicable
• Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)CompletedNCT02836080Not applicable
• Topiramate and Schizophrenia: Effects on Weight and PsychopathologyActive, not recruitingNCT02808533Not applicable
• Online Interventions for Gamblers With and Without Co-occurring Mental Health ConcernsCompletedNCT02800096Not applicable
• MR Imaging of Fat Deposition in Adolescents With First Time Antipsychotic UseCompletedNCT02744313
• Canadian rTMS Treatment and Biomarker Network in Depression TrialCompletedNCT02729792Not applicable
• Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy StudyStatus unknownNCT02714894
• Alcohol Effects on Driving-related Skills of Young DriversCompletedNCT02710578Not applicable
• Virtual Rehabilitation for the Treatment of Motivational Deficits in SchizophreniaCompletedNCT02709733Not applicable
• Switching Antipsychotics: Abrupt Discontinuation Versus OverlapCompletedNCT02640300Phase 4
• Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Use of rTMSCompletedNCT02537496Not applicable
• Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic SymptomsStatus unknownNCT02529163Not applicable
• Nicotine Metabolizers and [11C]-(+)-PHNOCompletedNCT02514720Not applicable
• Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project)CompletedNCT02488499Not applicable
• Efficacy and Biological Targets of Response to rTMS Therapy in Youth DepressionCompletedNCT02472470Not applicable
• The Effect of Cysteine, Tryptophan and Tyrosine Supplements on Breast MilkCompletedNCT02462746Phase 1
• Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine ReplacementTerminatedNCT02439944Phase 2/3
• A Study of the Effectiveness of Cognitive Adaptation Training in Early Intervention for PsychosisCompletedNCT02430935Not applicable
• Abuse Liability of Pregabalin and Its Effects on Benzodiazepine Withdrawal SymptomsTerminatedNCT02423018Phase 4
• DBT for Chronically Self-harming Individuals With BPD: Evaluating the Clinical & Cost Effectiveness of a 6 mo. TreatmentCompletedNCT02387736Not applicable
• Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD)Active, not recruitingNCT02386670Not applicable
• Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive DisorderCompletedNCT02362529Early Phase 1
• Cognitive Training in Inpatient Treatment for Substance Use DisordersCompletedNCT02356718Not applicable
• Commitment and Motivation in a Brief DBT Intervention for Self HarmCompletedNCT02354183Not applicable
• CAMH PARTNERs Integrated Care StudyActive, not recruitingNCT02345122Not applicable
• rTMS for Executive Function Deficits in Autism Spectrum DisorderCompletedNCT02311751Not applicable
• A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A)CompletedNCT02269540Early Phase 1
• Transdiagnostic iCBT for Depression and AnxietyCompletedNCT02266693Not applicable
• Breathing Focused Yoga in Social Anxiety DisorderCompletedNCT02266680Not applicable
• Incomplete Response in Late-Life Depression: Getting to Remission With BuprenorphineCompletedNCT02263248Phase 1/2
• Evaluating a Peer-Facilitated Skills-Based Intervention for Caregivers of Concurrent Disordered YouthCompletedNCT02243761Not applicable
• Does the Insula Control Smoking-Induced Dopamine Release? A TMS/[11C]-PHNO Study in Humans.CompletedNCT02212405Not applicable
• To Enhance Cognition in Late Life Depression Using Transcranial Direct Current StimulationCompletedNCT02212366Not applicable
• Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental IllnessCompletedNCT02167620Phase 4
• Neuroimaging MAO-B in Medication Free TR-MDD Using Novel TracerCompletedNCT02153281Not applicable
• The MATCH (Medication Aids for Tobacco Cessation and Health) StudyCompletedNCT02146911Not applicable
• Evaluation of the Healthy Relationships Plus Program for YouthCompletedNCT02140099Not applicable
• Feasibility Study of Oral Naloxone for Treatment of Methadone-induced ConstipationCompletedNCT02137213Phase 2
• An Acceptance-Based Behavioral Intervention vs. Nutritional Counselling for Weight Loss in Psychotic IllnessCompletedNCT02130596Not applicable
• Electronic Cigarettes in Daily Dependent SmokersCompletedNCT02108626Phase 4
• Abuse Liability of Controlled-Release Oxycodone FormulationsCompletedNCT02101840Phase 4
• Inflammation and Electroconvulsive TherapyTerminatedNCT02095639
• Development of Dietary Supplements for Mood Symptoms in PostpartumCompletedNCT02073175Phase 2
• Developing and Evaluating Effectiveness of a Reinstatement TutorialCompletedNCT02056314Not applicable
• A Dietary Supplement for Early Cigarette WithdrawalCompletedNCT02042521Phase 2
• Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine DependenceCompletedNCT01984177
• Parent Supports Intervention ProjectCompletedNCT01981070Not applicable
• Desvenlafaxine Monotherapy in DysthymiaCompletedNCT01948895Not applicable
• Effects of Varenicline on Plasticity in SchizophreniaCompletedNCT01934023Phase 2
• Brief Motivational Enhancement Therapy for Concurrent DisordersTerminatedNCT01924039Not applicable
• A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating DisorderCompletedNCT01921582Phase 2
• Randomized Controlled Trial of Conventional vs Theta Burst rTMSCompletedNCT01887782Not applicable
• rTMS for Working Memory Deficits in SchizophreniaCompletedNCT01880255Not applicable
• Randomized Controlled Trial of a Minimal Versus Extended Internet-based Intervention for Problem DrinkersCompletedNCT01874509Not applicable
• Deep rTMS for Treatment-Resistant Late-life DepressionCompletedNCT01860157Not applicable
• Effects of Varenicline on Smoking Lapse in Smokers With and Without SchizophreniaCompletedNCT01850953Phase 4
• Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's DiseaseCompletedNCT01847586Not applicable
• Lifestyle Intervention for Diabetes and Weight Management in PsychosisCompletedNCT01828931Not applicable
• Evaluating the Efficacy of Magnetic Seizure Therapy in Treatment Resistant Depression.WithdrawnNCT01748708Not applicable
• Deep Brain Stimulation (DBS) for the Management of Treatment Refractory Negative Symptoms in SchizophreniaWithdrawnNCT01725334Phase 1
• Transcranial Direct Current Stimulation in a Smoking Cessation TrialWithdrawnNCT01710410Phase 2
• Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PETCompletedNCT01699828Phase 1/2
• Evaluating the Effectiveness of Motivational Interviewing and a Dialectical Therapy Skills- Based Intervention for YouthCompletedNCT01656473Not applicable
• Prazosin for Smoking CessationTerminatedNCT01642433Phase 2
• Pharmacotherapy for Alcohol Dependence in Convicted Drinking DriversTerminatedNCT01638377Phase 4
• Dopamine Release in the Human Brain Following Alcohol AdministrationCompletedNCT01638364Phase 1
• Antipsychotic Augmentation With L-DopaCompletedNCT01636037Phase 2
• The Effect of Varenicline on D2/D3 Receptor Binding in SmokersCompletedNCT01632189Not applicable
• What is the Active Ingredient in Personalized Feedback Interventions for Problem Drinkers? A Randomized Controlled TrialCompletedNCT01608763Not applicable
• Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive DisorderCompletedNCT01596608Not applicable
• Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With SchizophreniaActive, not recruitingNCT01545999Not applicable
• Effects of rTMS on Cigarette Smoking and Cognition in SchizophreniaCompletedNCT01523730Not applicable
• Web-based Personalized Feedback for University StudentsCompletedNCT01521078Not applicable
• Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depressive DisorderCompletedNCT01515215Not applicable
• The Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Working MemoryCompletedNCT01494623Not applicable
• Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With SchizophreniaTerminatedNCT01465074Not applicable
• Randomized Controlled Trial of Mailed Nicotine Replacement Therapy to Canadian SmokersCompletedNCT01429129Phase 4
• Repetitive Transcranial Magnetic Stimulation for Refractory Auditory Hallucinations in SchizophreniaCompletedNCT01386918Not applicable
• Smoking-induced Dopamine Release: a [11C]-(+)-PHNO PET Study in HumansCompletedNCT01302262
• Varenicline in Drug TreatmentCompletedNCT01286584Phase 4
• Baclofen for Smoking Cessation in a Non-Psychiatric PopulationTerminatedNCT01228994Phase 2
• 20 Weeks DBT Group Skills Training StudyCompletedNCT01193205Phase 1
• Pilot Study of Text Message Brief Interventions for Problem DrinkersCompletedNCT01180829Not applicable
• My Depression Wellness Toolkit StudyCompletedNCT01178424Not applicable
• Helping Problem Drinkers on the InternetCompletedNCT01114919Not applicable
• Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar DisorderCompletedNCT01093937Not applicable
• Effect of Varenicline on Cognitive Function in Cigarette Smokers With SchizophreniaCompletedNCT01093365Phase 2

← Centre for Addiction and Mental Health overview and focus areas